Journal of Cancer
ISSN: 1837-9664
3.2
Impact Factor
ISSN: 1837-9664
Global reach, higher impact
J Cancer 2011; 2:347-349. doi:10.7150/jca.2.347 This volume Cite
Short Report
Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC)
Department of Hematology, Istituto Scientifico San Raffaele, Milano, Italy
Citation:
Bregni M, Ciceri F, Peccatori J. Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC). J Cancer 2011; 2:347-349. doi:10.7150/jca.2.347. https://www.jcancer.org/v02p0347.htm
Other stylesAbstract
A variety of therapeutic options are now available for advanced renal cell cancer, including antiangiogenic and anti-mTOR agents. Allogeneic hematopoietic stem cell transplantation, through its graft-versus-tumor effect, can induce clinical responses and prolonged survival in selected cytokine-refractory patients. However, the still relevant transplant-related mortality due to toxicity and graft-versus-host disease is an obstacle to its widespread use.
Keywords: Allogeneic hematopoietic stem cell transplantation, advanced renal cell cancer, graft-versus-tumor.
Citation styles
APA
Bregni, M., Ciceri, F., Peccatori, J. (2011). Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC). Journal of Cancer, 2, 347-349. https://doi.org/10.7150/jca.2.347.
ACS
Bregni, M.; Ciceri, F.; Peccatori, J. Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC). J. Cancer 2011, 2, 347-349. DOI: 10.7150/jca.2.347.
NLM
Bregni M, Ciceri F, Peccatori J. Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC). J Cancer 2011; 2:347-349. doi:10.7150/jca.2.347. https://www.jcancer.org/v02p0347.htm
CSE
Bregni M, Ciceri F, Peccatori J. 2011. Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC). J Cancer. 2:347-349.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.